Epithalon: Research Overview, Mechanisms, and Current Evidence
Epithalon (also called Epitalon or AEDG) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly, modeled on the amino acid composition of a pineal gland extract. In preclinical research it has been studied for geroprotective and antioxidant effects, including reports that it can activate telomerase and lengthen telomeres in cultured human cells. The information below summarizes published research for educational and research purposes only. It is not medical advice and is not guidance for use in humans.
Available for research use from our preferred vendor, Project Zero. For laboratory research use only.
How It Works (Preclinical Mechanisms)
In preclinical models, Epithalon has been reported to influence gene expression, telomere biology, and antioxidant pathways, though its full mechanism remains uncertain.
- Reported to induce expression and activity of telomerase, the enzyme that maintains telomeres, in cultured human cells.
- Studied for direct effects on gene transcription, with proposed binding sites in promoter regions of certain genes.
- Investigated for antioxidant and antimutagenic effects in cell and animal models.
- Reported to influence melatonin synthesis and neuroendocrine signaling in preclinical work.
Areas of Research Interest
Published studies have examined Epithalon in the following research contexts. The evidence is largely in vitro and from older animal studies, with limited modern human data.
Telomere and cellular aging
Studied in human fibroblast cultures for effects on telomerase activity, telomere length, and proliferative capacity.
Gene transcription
Investigated for proposed direct interactions with promoter regions of genes such as telomerase.
Antioxidant and neuroendocrine effects
Examined in models for antioxidant, antimutagenic, and melatonin-related activity.
Geroprotection
Studied in animal models for effects framed around healthy aging and stress resistance.
Reported Study Parameters
For laboratory research use only. The table below reports the doses and routes used in specific published studies, with sources. It describes what researchers administered in these models and is not a protocol, recommendation, or guidance for use in humans or animals. Animal-study doses are expressed per kilogram of body weight.
| Research Model | Dose and Route Reported | Source |
|---|---|---|
| Human fibroblast culture (telomerase and telomere length) | Added to culture medium; concentrations of 10, 50, and 100 ng/mL tested, with best effects at 10 ng/mL after 28 days | Araj 2025·DOI |
| Human fetal fibroblasts (proliferative capacity) | Added to aging cell culture; cells made about 10 extra divisions versus control | Khavinson 2004·DOI |
| Human research | No validated clinical regimen established; published evidence is largely in vitro and from older animal studies | Araj 2025·DOI |
Products are supplied as lyophilized powder requiring reconstitution. For reconstitution concentration math, use the Peptide Calculator.
Latest Research (2003 to 2025)
Peer-reviewed literature indexed on PubMed includes a recent overview alongside the foundational cell studies that first reported Epithalon's telomere effects.
Overview of Epitalon (review)
A 2025 review summarized 25 years of in vitro, in vivo, and in silico research on Epithalon, describing geroprotective and neuroendocrine effects linked to antioxidant, neuroprotective, and antimutagenic mechanisms, while noting that the full mechanism and structural data remain limited. PubMed·DOI
Overcoming the cell division limit
A 2004 study reported that adding Epithalon to aging human fetal fibroblast cultures lengthened telomeres and allowed about 10 extra cell divisions compared with untreated controls, framed as overcoming the Hayflick limit. PubMed·DOI
Telomerase activity in somatic cells
A 2003 study reported that Epithalon induced telomerase activity and telomere elongation in telomerase-negative human fetal fibroblasts, which the authors interpreted as reactivation of the telomerase gene in somatic cells. PubMed·DOI
Effects on gene transcription
A 2003 study proposed that Epithalon could directly initiate transcription of certain genes, identifying candidate binding sites in the promoter regions of telomerase and other genes. PubMed·DOI
Research Questions
What is Epithalon?
Epithalon is a synthetic four-amino-acid peptide (Ala-Glu-Asp-Gly) based on a pineal gland extract, studied mainly for telomere and antioxidant effects in preclinical models.
What is the current state of human evidence?
Modern, controlled human data are limited. Most of the influential findings are from cell cultures and older animal studies, so the human evidence base is considered preliminary.
What does the available safety literature suggest?
There is little rigorous human safety data. Because the evidence is largely preclinical and from limited sources, Epithalon should be treated as investigational for research purposes.
Referenced Citations
Literature indexed on PubMed.
- Araj, S.K., et al. (2025). Overview of Epitalon: highly bioactive pineal tetrapeptide with promising properties. Int. J. Mol. Sci., 26(6), 2691. PubMed·DOI
- Khavinson, V.Kh., et al. (2004). Peptide promotes overcoming of the division limit in human somatic cell. Bull. Exp. Biol. Med., 137(5), 503-506. PubMed·DOI
- Khavinson, V.Kh., et al. (2003). Effect of regulatory peptides on gene transcription. Bull. Exp. Biol. Med., 136(3), 288-290. PubMed·DOI
- Khavinson, V.Kh., Bondarev, I.E., & Butyugov, A.A. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull. Exp. Biol. Med., 135(6), 590-592. PubMed·DOI
PeptideInfo.org provides information strictly for educational and research purposes. All referenced products are intended for laboratory and research use only and are not approved for human consumption, medical use, or self-administration. Nothing on this page constitutes medical advice. Research summaries reference literature indexed on PubMed.